Screening for atrial fibrillation with ECG to reduce stroke – a randomised controlled trial

Not Applicable

• Conditions: Atrial fibrillation; Circulatory System; Atrial fibrillation and flutter

• Registration Number: ISRCTN72104369
• Lead Sponsor: niversity of Cambridge

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36691194/ Pilot (added 24/01/2023) 2025 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38670614/ Main study (added 02/05/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-11
• Last Update Posted: 13 May 2024
• Study Completion: 2028-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 89575

Inclusion Criteria

1. Have given informed consent to participate
2. Be aged 70 years or over

Exclusion Criteria

Current exclusion criteria as of 08/01/2024 to 25/07/2022:
1. On anticoagulation therapy
2. On the practice palliative care register
3. Resident in a nursing or care or residential home
4. Consented to another trial that will affect participation in SAFER
5. Non-UK resident

_____

Previous exclusion criteria as of 25/07/2022:
1. On long-term anticoagulation therapy
2. On the practice palliative care register
3. Resident in a nursing or care or residential home
4. Consented to another trial that will affect participation in SAFER
5. Non-UK resident

_____

Previous exclusion criteria:
1. Long-term anticoagulation therapy for stroke prevention
2. On the palliative care register
3. Resident in a nursing/care/residential home

Study & Design

• Study Type: Interventional
• Study Design: Not specified